FDA’s View on Cannabis

The U.S. Food and Drug Administration (FDA) is continuing to support clinical research for cannabis and psychedelic drug development. On the heels of publishing its first draft guidance on clinical trials involving psychedelic drugs last year, the FDA acknowledged that there is scientific support for the use of cannabis as a medical treatment, and it joined the […]